Evidence map›Paper›PMID 31561508›Full record

ArticleCancers2019

Data Fusion Techniques for the Integration of Multi-Domain Genomic Data from Uveal Melanoma.

Max Pfeffer, André Uschmajew, Adriana Amaro, Ulrich Pfeffer

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Machine Learning Methods for Gene Selection in Uveal Melanoma.International journal of molecular sciences · 2024
    Article
  2. Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis.International journal of molecular sciences · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Uveal Melanoma.Cancers · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Max PfefferMax Planck Institute for Mathematics in the Sciences, 04103 Leipzig, Germany. pfeffer@mis.mpg.de.
André UschmajewMax Planck Institute for Mathematics in the Sciences, 04103 Leipzig, Germany. uschmajew@mis.mpg.de.
Adriana AmaroIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy. adriana.amaro82@gmail.com.
Ulrich PfefferIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy. patologia.molecolare.integrata@gmail.com.ORCID 0000-0003-0872-4671

Funding

Associazione Italiana per la Ricerca sul Cancro 21073
6 · The paper itself

Abstract

Uveal melanoma (UM) is a rare cancer that is well characterized at the molecular level. Two to four classes have been identified by the analyses of gene expression (mRNA, ncRNA), DNA copy number, DNA-methylation and somatic mutations yet no factual integration of these data has been reported. We therefore applied novel algorithms for data fusion, joint Singular Value Decomposition (jSVD) and joint Constrained Matrix Factorization (jCMF), as well as similarity network fusion (SNF), for the integration of gene expression, methylation and copy number data that we applied to the Cancer Genome Atlas (TCGA) UM dataset. Variant features that most strongly impact on definition of classes were extracted for biological interpretation of the classes. Data fusion allows for the identification of the two to four classes previously described. Not all of these classes are evident at all levels indicating that integrative analyses add to genomic discrimination power. The classes are also characterized by different frequencies of somatic mutations in putative driver genes (GNAQ, GNA11, SF3B1, BAP1). Innovative data fusion techniques confirm, as expected, the existence of two main types of uveal melanoma mainly characterized by copy number alterations. Subtypes were also confirmed but are somewhat less defined. Data fusion allows for real integration of multi-domain genomic data.

Indexed as

constrained matrix factorizationcopy number alterationdata fusionDNA-methylationgene expression profilemetastasissimilarity network fusionsingular value decompositiontumor classificationtumor subtypes

Identifiers

PMID31561508
PMCPMC6826760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.